At a Glance
| Noopept | Aniracetam | |
|---|---|---|
| Class | Nootropic | Nootropic |
| Common Dose (oral) | 10–30 mg | 1200–1800 mg |
| Total Duration | 20–60 hrs | 0.8–1.5 hrs |
| Routes | OralSublingual | oral |
Noopept, a Nootropic, and Aniracetam, a Nootropic, are frequently compared by users looking to understand their relative effects, dosage profiles, and safety considerations. Both are classified as Nootropics, meaning they share a common pharmacological foundation. They share 0 documented effects in common, with 0 effects unique to Noopept and 21 unique to Aniracetam. This side-by-side comparison covers dosage, duration, subjective effects, and safety to help you make informed decisions.
| Noopept | Aniracetam | |
|---|---|---|
| Class | Nootropic | Nootropic |
| Common Dose (oral) | 10–30 mg | 1200–1800 mg |
| Total Duration | 20–60 hrs | 0.8–1.5 hrs |
| Routes | OralSublingual | oral |
| Effects | 0 documented | 21 documented |
| Level | Noopept | Aniracetam |
|---|---|---|
| Threshold | 5 mg | 350 mg |
| Light | 5–10 mg | 500–1200 mg |
| Common | 10–30 mg | 1200–1800 mg |
| Strong | 30–40 mg | 1800–2400 mg |
| Heavy | 60 mg | 2400 mg |
| Level | Dose |
|---|---|
| Threshold | 5 mg |
| Light | 5–10 mg |
| Common | 10–20 mg |
| Strong | 20–30 mg |
| Heavy | 40 mg |
Noopept
Aniracetam
No direct interaction data available between these substances. This does not mean the combination is safe.
No dangerous interactions recorded.
No dangerous interactions recorded.